VETOLEXIN 100 PASTE

Land: Kanada

Sprache: Englisch

Quelle: Health Canada

Wirkstoff:

CEPHALEXIN (CEPHALEXIN MONOHYDRATE)

Verfügbar ab:

VETOQUINOL N A INC

Dosierung:

100MG

Darreichungsform:

PASTE

Zusammensetzung:

CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 100MG

Verabreichungsweg:

ORAL

Einheiten im Paket:

6X15 ML SYR

Verschreibungstyp:

Prescription

Therapiegruppe:

DOGS

Produktbesonderheiten:

Active ingredient group (AIG) number: 0105911005

Berechtigungsstatus:

CANCELLED POST MARKET

Berechtigungsdatum:

2019-02-04

Gebrauchsinformation

VETOQUINOL N.-A. INC.
Commercial Division
2000, CHEMIN GEORGES, LAVALTRIE, QC, J5T 3S5
Telephone:
450-586-2252
Order Desk: 800-363-1700
Fax:
450-586-4649
Website:
www.vetoquinol.ca
Email:
[e-mail]
Every effort has been made to ensure the accuracy of the information
published. However, it remains the responsibility of the
readers to familiarize themselves with the product information
contained on the Canada product label or package insert.
VETOLEXIN
®
VÉTOQUINOL
Cephalexin Oral Paste
VETERINARY USE ONLY
Meat flavour
PR
VETOLEXIN 100
DIN 02353911
ACTIVE INGREDIENTS: Each mL of paste contains 100 mg Cephalexin (as
monohydrate) in a triglyceride base.
PR
VETOLEXIN 250
DIN 02353938
ACTIVE INGREDIENTS: Each mL of paste contains 250 mg Cephalexin (as
monohydrate) in a triglyceride base.
INDICATION
Antibiotic for the treatment of canine superficial pyoderma caused by
susceptible strains of
Staphylococcus intermedius.
Note: It is recommended to obtain samples for in vitro culture and
susceptibility testing prior to treatment. When this is not
practical, culture and susceptibility results after initiation of
VETOLEXIN therapy should be reviewed to confirm susceptibility
of the pathogens.
DOSAGE AND ADMINISTRATION
Administer orally 25 mg/kg every 8 to 12 hours for 2 to 4 weeks.
VETOLEXIN can be given with or without food. Administer
directly into the dogs mouth or onto its food.
The determination of a dosage regimen for any particular patient
should take into consideration factors such as the
severity and the nature of the infection, susceptibility of the
causative organisms, clinical experience and the integrity of the
host-defence mechanisms. When treating dogs with superficial pyoderma,
it is recommended to continue treatment for
7 days beyond a clinical cure. If no clinical improvement is seen
after 3-5 days of treatment, therapy should be
discontinued and the case re-evaluated.
HOW TO USE THE DIAL-A-DOSE SYRINGE
1. Hold the syringe with the tip pointing upward (make sure the cap is
still secured) and the ma